Latest filing published 06 Jan 2026 for Protagonist Therapeutics, Inc.
Sarah A. O'Dowd appears in 43 filings: 35 at LAM Research Corp (SVP, Chief Legal Officer), 6 at Ichor Holdings, Ltd. and 2 at Protagonist Therapeutics, Inc, the latter two as Director. No purchase is found there.
The 8 sales in the record amount to EUR 10,930,048, with a median of EUR 1,014,861. Three stand out, all at LAM Research: EUR 4,699,403 on September 11, 2019, EUR 1,816,376 on March 22, 2018 and EUR 1,353,586 on June 22, 2017. The rest of the flow counts 28 share grants, 5 option exercises and 2 filings of another kind.
Four years hold most of it: 7 filings in 2016, 9 in 2017, 8 in 2018 and 11 in 2019. Since 2021 the record has only one a year, and 2 in 2020. Between the trade and its publication, the median delay is 4 days. The single filing of the past year is neither a purchase nor a sale.
Within 30 days of colleagues at LAM Research Corp, O'Dowd has 7, 6 and 6 own market trades, in that order. All on the same side. In the same order, the colleagues are Richard A. Gottscho, Patrick J. Lord and Timothy Archer.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 43 declarations